A comprehensive examination of Low Dose Naltrexone--a little-known
drug with big potential
"[LDN] raises hopes of reversing memory loss in old age."--the
Guardian
A drug that is simultaneously affordable, devoid of severe side effects,
and applicable to a wide range of diseases is not often found in the
modern pharmaceutical landscape. But as medical professionals and
researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts
this remarkable combination.
LDN, originally prescribed in higher doses as a treatment for opioid
addiction, works by blocking opioid receptors, thereby stimulating the
production of endorphins, mitigating the inflammatory process, and
stabilizing the immune response. Prescribed off-label and administered
in small daily doses, this generic drug has proven useful in treating
many different ailments.
Expanding on the information presented in The LDN Book, Volume 1,
which showcased LDN's efficacy in treating conditions such as lupus,
thyroiditis, autism spectrum disorder, and chronic fatigue, Volume 2
highlights the latest clinical trials, case studies, and research with
explanations from a dozen medical professionals on how they are using
LDN to help patients suffering from:
- Chronic pain
- Parkinson's disease
- Dermatologic conditions
- Traumatic brain injury
- Lyme disease and more
The LDN Book, Volume 2 is both a resource for practitioners,
pharmacists, and patients, and a renewed call for further research on
the healing potential of this generic drug.